ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
MIAMI, Aug. 07, 2017 -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, health practice risk management, announces new independent board member, Jervis Hough, MS, CSCP ®.
On August 4, 2017, Progressive Care executed an agreement with Mr. Jervis Hough to be a member of the Board of Directors. Mr. Hough is a veteran brokerage professional and regulatory consultant who has provided guidance to firms engaged in all areas of capital markets including brokerage, investment advisory, off-exchange foreign currency, and pooled investment vehicles (e.g. hedge funds, venture capital funds, and private equity). His experience includes, Chief Compliance Officer of IFS Securities, Inc., past CEO of FundAmerica Securities, President of Capital and Credit International, Inc., Consultant with Capital Markets Compliance, LLC (CMC), Assistant Vice President for Banc of America Investment Services, Inc, and Compliance Examiner for FINRA (fka NASD). Mr. Hough currently holds the Series 7, 24, 53, 63, 79, and 99. He is also a Certified Securities Compliance Professional.
“I have known Progressive Care’s management team for over 10 years and was honored to be asked to join the team as a member of the Board of Directors. Healthcare is one of the most important aspects of a person’s life. I believe that Progressive Care has the right mission and vision to be a front line healthcare leader,” said Jervis B. Hough, CCO, IFS Securities.
“Having known Mr. Hough for years, I am confident in his ability to lend his talent and expertise to elevating Progressive Care to the next level,” stated S. Parikh Mars, CEO. “We asked him to join our Board because of his extensive knowledge in navigating FINRA and SEC matters, his ability to analyze and take advantage of capital markets, and his expansive network of professional affiliations that will allow us to have access to some of the brightest minds and most reputable firms in America.”
About Progressive Care
Progressive Care, Inc. (OTC PINK:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target”, “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact Armen Karapetyan Senior Advisor Business Development [email protected]
